✦ LIBER ✦

Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?

✍ Scribed by Li, E. K.; Tam, L.-S.; Zhu, T. Y.; Li, M.; Kwok, C. L.; Li, T. K.; Leung, Y. Y.; Wong, K. C.; Szeto, C. C.

Book ID: 125501837
Publisher: Oxford University Press
Year: 2009
Tongue: English
Weight: 172 KB
Volume: 48
Category: Article
ISSN: 1462-0324
DOI: 10.1093/rheumatology/kep124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histopathologic and clinical outcome of

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis

✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn Jónsdóttir; Stefan H. Jacobson; Elisa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose

In lupus nephritis, the benefit of ritux

In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: Comment on the article by Sfikakis et al

✍ Ronald van Vollenhoven; Iva Gunnarsson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Rituximab is effective in the treatment

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy

✍ R Martínez, A Muñoz, M L Velloso, S Rodríguez Montero… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 119 KB

Biopsy-verified response of severe lupus

Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone

✍ Vollenhoven, RF van; Gunnarsson, I; Welin-Henriksson, E; Sundelin, B; Österborg, 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 248 KB

Rituximab in combination with fludarabin

Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma

✍ Stefano Sacchi; Samantha Pozzi; Raffaella Marcheselli; Massimo Federico; Alessan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## BACKGROUND. The current study was conducted to asses the safety profile and clinical activity of rituximab in combination with fludarabine and cyclophosphamide in patients with recurrent follicular lymphoma (FL). ## METHODS. This study was a noncomparative, multicenter, phase II s

Treatment with cyclophosphamide delays t

Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis

✍ Cecile Grootscholten; Ingeborg M. Bajema; Sandrine Florquin; Eric J. Steenbergen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## Objective To analyze the effect of treatment with either pulse cyclophosphamide (CYC) or azathioprine (AZA) combined with methylprednisolone (MP), on serial biopsy results in patients with proliferative lupus nephritis, and to evaluate the predictive value of various histopathologic